Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Friday, May 9, 2008

Boston Scientific wins Canadian court dismissal of J&J suit

A Canadian court has dismissed a lawsuit from Johnson & Johnson against Boston Scientific Corp. for infringing on two of Johnson & Johnson's patents related to stents, according to Boston Scientific.

Natick-based Boston Scientific (NYSE: BSX) and medical products powerhouse Johnson & Johnson are arch competitors in the multibillion-dollar market for stents, which are metal tubes used to prop open arteries after surgeries to remove blockages.

Johnson & Johnson, based in New Jersey, claimed in the now-dismissed lawsuit that Boston Scientific's NIR stent infringed on the two patents. Yet Boston Scientific said it faces a separate lawsuit from Johnson & Johnson in which its competitor claims that its Taxus and Express stents infringe on the same two patents.

Boston Scientific, a global developer, manufacturer and distributor of medical devices, reported a 2007 net loss of $495 million on revenue of $8.4 billion. The firm employed 27,500 workers worldwide as of December 2007.

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Tech Pulse Poll

What's your level of interest in Pinterest?



View Results

Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.